GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (FRA:UK2) » Definitions » Cash Flow from Investing

Shandong Weigao Group Medical Polymer Co (FRA:UK2) Cash Flow from Investing : €-201 Mil (TTM As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Jun. 2024, Shandong Weigao Group Medical Polymer Co spent €0 Mil on purchasing property, plant, equipment. It gained €0 Mil from selling property, plant, and equipment. It spent €0 Mil on purchasing business. It gained €0 Mil from selling business. It spent €0 Mil on purchasing investments. It gained €0 Mil from selling investments. It paid €0Mil for net Intangibles purchase and sale. And it paid €0 Mil for other investing activities. In all, Shandong Weigao Group Medical Polymer Co spent €57 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Jun. 2024.


Shandong Weigao Group Medical Polymer Co Cash Flow from Investing Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Cash Flow from Investing Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -171.60 48.22 -210.92 -344.88 -178.33

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -145.25 -205.69 -34.56 -143.89 -57.28

Shandong Weigao Group Medical Polymer Co Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Shandong Weigao Group Medical Polymer Co's Cash Flow from Investing for the fiscal year that ended in Dec. 2023 is calculated as:

Shandong Weigao Group Medical Polymer Co's Cash Flow from Investing for the quarter that ended in Jun. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-201 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Weigao Group Medical Polymer Co  (FRA:UK2) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Shandong Weigao Group Medical Polymer Co's purchase of property, plant, equipment for the six months ended in Jun. 2024 was €0 Mil. It means Shandong Weigao Group Medical Polymer Co spent €0 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Shandong Weigao Group Medical Polymer Co's sale of property, plant, equipment for the six months ended in Jun. 2024 was €0 Mil. It means Shandong Weigao Group Medical Polymer Co gained €0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Shandong Weigao Group Medical Polymer Co's purchase of business for the six months ended in Jun. 2024 was €0 Mil. It means Shandong Weigao Group Medical Polymer Co spent €0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Shandong Weigao Group Medical Polymer Co's sale of business for the six months ended in Jun. 2024 was €0 Mil. It means Shandong Weigao Group Medical Polymer Co gained €0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Shandong Weigao Group Medical Polymer Co's purchase of investment for the six months ended in Jun. 2024 was €0 Mil. It means Shandong Weigao Group Medical Polymer Co spent {stock_data.stock.currency_symbol}}0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Shandong Weigao Group Medical Polymer Co's sale of investment for the six months ended in Jun. 2024 was €0 Mil. It means Shandong Weigao Group Medical Polymer Co gained €0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Shandong Weigao Group Medical Polymer Co's net Intangibles purchase and sale for the six months ended in Jun. 2024 was €0 Mil. It means Shandong Weigao Group Medical Polymer Co paid €0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Shandong Weigao Group Medical Polymer Co's cash from discontinued investing activities for the six months ended in Jun. 2024 was 0 Mil. It means Shandong Weigao Group Medical Polymer Co paid €0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Shandong Weigao Group Medical Polymer Co's cash from other investing activities for the six months ended in Jun. 2024 was €0 Mil. It means Shandong Weigao Group Medical Polymer Co paid €0 Mil for other investing activities.


Shandong Weigao Group Medical Polymer Co Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Weigao Group Medical Polymer Co Business Description

Traded in Other Exchanges
Address
No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co Headlines

No Headlines